Craig A. Tooman

Insider Reports History

Entity
Individual
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Craig A. Tooman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Silence Therapeutics plc President and CEO, Director Employee Share Option (Right to Buy) 900K Jan 2, 2025 Direct
Silence Therapeutics plc President and CEO, Director Ordinary Shares 33.5K Jan 2, 2025 Direct

Insider Reports Filed by Craig A. Tooman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLN Silence Therapeutics plc Jan 2, 2025 1 $0 4 Jan 6, 2025 President and CEO, Director
SLN Silence Therapeutics plc Jan 2, 2025 0 $0 3 Jan 2, 2025 President and CEO, Director